Coastline Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.3K | Hold |
68
| – | – | ﹤0.01% | 335 |
|
|
2025
Q4 | $16.4K | Sell |
68
-8
| -11% | -$2.05K | ﹤0.01% | 324 |
|
|
2025
Q3 | $20.8K | Hold |
76
| – | – | ﹤0.01% | 307 |
|
|
2025
Q2 | $19.6K | Hold |
76
| – | – | ﹤0.01% | 311 |
|
|
2025
Q1 | $17K | Hold |
76
| – | – | ﹤0.01% | 315 |
|
|
2024
Q4 | $17.4K | Hold |
76
| – | – | ﹤0.01% | 331 |
|
|
2024
Q3 | $18.6K | Buy |
+76
| New | +$17K | ﹤0.01% | 341 |
|
|
2024
Q1 | – | Sell |
-3,106
| Closed | -$534K | – | 261 |
|
|
2023
Q4 | $534K | Sell |
3,106
-175
| -5% | -$26.9K | 0.07% | 184 |
|
|
2023
Q3 | $485K | Sell |
3,281
-385
| -11% | -$69.6K | 0.07% | 191 |
|
|
2023
Q2 | $801K | Sell |
3,666
-4,182
| -53% | -$932K | 0.11% | 163 |
|
|
2023
Q1 | $1.72M | Sell |
7,848
-9,462
| -55% | -$2.05M | 0.25% | 112 |
|
|
2022
Q4 | $3.6M | Sell |
17,310
-3,670
| -17% | -$806K | 0.54% | 52 |
|
|
2022
Q3 | $4.58M | Sell |
20,980
-310
| -1% | -$70.6K | 0.73% | 32 |
|
|
2022
Q2 | $4.46M | Sell |
21,290
-65
| -0.3% | -$13.8K | 0.66% | 37 |
|
|
2022
Q1 | $5.18M | Sell |
21,355
-785
| -4% | -$190K | 0.63% | 43 |
|
|
2021
Q4 | $5.77M | Sell |
22,140
-130
| -0.6% | -$33.7K | 0.66% | 39 |
|
|
2021
Q3 | $5.87M | Sell |
22,270
-435
| -2% | -$119K | 0.73% | 32 |
|
|
2021
Q2 | $5.6M | Sell |
22,705
-845
| -4% | -$178K | 0.69% | 35 |
|
|
2021
Q1 | $4.57M | Sell |
23,550
-1,740
| -7% | -$349K | 0.59% | 50 |
|
|
2020
Q4 | $5.38M | Buy |
25,290
+185
| +0.7% | +$36.9K | 0.72% | 34 |
|
|
2020
Q3 | $4.3M | Sell |
25,105
-860
| -3% | -$159K | 0.65% | 44 |
|
|
2020
Q2 | $4.99M | Sell |
25,965
-470
| -2% | -$76.9K | 0.79% | 30 |
|
|
2020
Q1 | $3.89M | Sell |
26,435
-1,060
| -4% | -$169K | 0.7% | 42 |
|
|
2019
Q4 | $4.26M | Sell |
27,495
-315
| -1% | -$45.4K | 0.59% | 47 |
|
|
2019
Q3 | $3.76M | Buy |
27,810
+200
| +0.7% | +$26.2K | 0.55% | 55 |
|
|
2019
Q2 | $3.37M | Buy |
27,610
+1,000
| +4% | +$111K | 0.49% | 68 |
|
|
2019
Q1 | $2.77M | Buy |
26,610
+2,300
| +9% | +$237K | 0.41% | 84 |
|
|
2018
Q4 | $2.77M | Buy |
24,310
+615
| +3% | +$65.9K | 0.48% | 72 |
|
|
2018
Q3 | $2.73M | Buy |
23,695
+1,860
| +9% | +$204K | 0.39% | 89 |
|
|
2018
Q2 | $2.26M | Buy |
21,835
+1,820
| +9% | +$184K | 0.34% | 106 |
|
|
2018
Q1 | $1.97M | Buy |
20,015
+2,010
| +11% | +$190K | 0.3% | 121 |
|
|
2017
Q4 | $1.52M | Buy |
18,005
+3,390
| +23% | +$280K | 0.23% | 145 |
|
|
2017
Q3 | $1.13M | Buy |
14,615
+4,130
| +39% | +$316K | 0.2% | 157 |
|
|
2017
Q2 | $816K | Buy |
10,485
+1,160
| +12% | +$83K | 0.15% | 187 |
|
|
2017
Q1 | $671K | Buy |
+9,325
| New | +$644K | 0.13% | 198 |
|
Other funds holding RMD
VCM
VPM
DAM
Coastline Trust's RMD Position: Q1 2026 in Review
Coastline Trust held its ResMed (RMD) position steady in Q1 2026 at 68 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #335.
Coastline Trust first reported a position in RMD in Q1 2017 and has held it in 35 quarters since. The position peaked at $5.87M in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Coastline Trust held 68 shares of ResMed worth $15.3K as of Q1 2026.
- Coastline Trust left its ResMed share count unchanged in Q1 2026.
- ResMed made up ﹤0.01% of Coastline Trust's portfolio in Q1 2026, its #335 holding.
- Coastline Trust first reported a position in ResMed in Q1 2017 and has held it in 35 quarters since.
- Coastline Trust's ResMed position peaked at $5.87M in Q3 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Coastline Trust's 13F filing for Q1 2026, filed 3 Apr 2026.